Incomplete Kawasaki Disease in a Child with Covid-19.
作者信息
Rivera-Figueroa Elvia I, Santos Roberto, Simpson Scott, Garg Padma
机构信息
Division of Pediatric Critical Care Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Division of Pediatric Infectious Disease, University of Mississippi Medical Center, Jackson, Mississippi, USA.
出版信息
Indian Pediatr. 2020 Jul 15;57(7):680-681. doi: 10.1007/s13312-020-1900-0. Epub 2020 May 9.
Abstract
摘要
相似文献
1
Incomplete Kawasaki Disease in a Child with Covid-19.一名感染新冠病毒的儿童患不完全川崎病
Indian Pediatr. 2020 Jul 15;57(7):680-681. doi: 10.1007/s13312-020-1900-0. Epub 2020 May 9.
2
The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children.新型冠状病毒（COVID-19）与儿童川崎病风险
J Formos Med Assoc. 2020 Nov;119(11):1713-1714. doi: 10.1016/j.jfma.2020.05.030. Epub 2020 May 23.
3
Kawasaki Disease Features and Myocarditis in a Patient with COVID-19.一名新冠肺炎患者的川崎病特征与心肌炎
Pediatr Cardiol. 2020 Oct;41(7):1526-1528. doi: 10.1007/s00246-020-02393-0. Epub 2020 Jun 15.
4
Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic.通过疫情界定新冠病毒疾病（COVID-19）与儿童多系统炎症综合征之间的关联。
J Korean Med Sci. 2020 Jun 8;35(22):e204. doi: 10.3346/jkms.2020.35.e204.
5
Kawasaki disease fact check: Myths, misconceptions and mysteries.川崎病事实核查：误区、误解与谜团
J Paediatr Child Health. 2020 Sep;56(9):1343-1345. doi: 10.1111/jpc.15101. Epub 2020 Aug 8.
6
Kawasaki disease epidemic: pitfalls.川崎病流行：陷阱。
Ital J Pediatr. 2020 Aug 27;46(1):121. doi: 10.1186/s13052-020-00887-4.
7
COVID-19 and Kawasaki syndrome: should we really be surprised?新冠病毒与川崎病：我们真的应该感到惊讶吗？
Cardiol Young. 2020 Jul;30(7):1059-1060. doi: 10.1017/S1047951120001432. Epub 2020 Jun 25.
8
Association Between COVID-19 and Kawasaki Disease: Vigilance Required From Otolaryngologists.新型冠状病毒肺炎与川崎病的关联：耳鼻喉科医生需保持警惕。
Otolaryngol Head Neck Surg. 2020 Aug;163(2):316-317. doi: 10.1177/0194599820930238. Epub 2020 May 19.
9
COVID-19 and Kawasaki Disease: Novel Virus and Novel Case.新型冠状病毒肺炎与川崎病：新型病毒与新型病例。
Hosp Pediatr. 2020 Jun;10(6):537-540. doi: 10.1542/hpeds.2020-0123. Epub 2020 Apr 7.
10
Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.儿童 COVID-19 感染相关的多形性红斑和川崎病。
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e539-e541. doi: 10.1111/jdv.16666. Epub 2020 Jul 6.
引用本文的文献
1
Kawasaki disease in Colombia: A systematic review and contrast with multisystem inflammatory syndrome in children associated with COVID-19.哥伦比亚的川崎病：一项系统综述以及与儿童 COVID-19 相关多系统炎症综合征的对比
Rev Colomb Reumatol. 2022 Jun;29:S66-S76. doi: 10.1016/j.rcreu.2020.11.004. Epub 2021 Jan 28.
2
[Multisystemic inflammatory syndrome in children with COVID-19: a rheumatology perspective].[新型冠状病毒肺炎患儿的多系统炎症综合征：风湿病学视角]
Rev Colomb Reumatol. 2021 Oct-Dec;28(4):289-299. doi: 10.1016/j.rcreu.2020.09.005. Epub 2020 Oct 17.
3
Similarity of immune-associated markers in COVID-19 and Kawasaki disease: analyses from bioinformatics and machine learning.新型冠状病毒肺炎与川崎病中免疫相关标志物的相似性：来自生物信息学和机器学习的分析
BMC Pediatr. 2025 May 19;25(1):400. doi: 10.1186/s12887-025-05752-z.
4
Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms.新冠病毒症状学的全患者知识建模揭示了常见分子机制。
Front Mol Med. 2023 Jan 4;2:1035290. doi: 10.3389/fmmed.2022.1035290. eCollection 2022.
5
Emerging evidence of microbial infection in causing systematic immune vasculitis in Kawasaki disease.微生物感染在川崎病中引发系统性免疫性血管炎的新证据。
Front Microbiol. 2023 Dec 22;14:1313838. doi: 10.3389/fmicb.2023.1313838. eCollection 2023.
6
Multisystem Inflammatory Syndrome in Children (MIS-C) in a Low-income Country: What Treatment Should be Adopted in Case of a Lack of Immunoglobulin?儿童多系统炎症综合征（MIS-C）在低收入国家：如果缺乏免疫球蛋白，应采用何种治疗方法？
Rev Recent Clin Trials. 2024;19(2):150-157. doi: 10.2174/0115748871257131231204114803.
7
Cytokine Profiling among Children with Multisystem Inflammatory Syndrome versus Simple COVID-19 Infection: A Study from Northwest Saudi Arabia.多系统炎症综合征患儿与单纯新冠病毒感染患儿的细胞因子谱分析：沙特阿拉伯西北部的一项研究
Biology (Basel). 2022 Jun 21;11(7):946. doi: 10.3390/biology11070946.
8
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era.德尔塔（B.1.617.2）和奥密克戎（B.1.1.529）变异株流行时期儿童人群中 SARS-CoV-2 感染情况。
Virol J. 2022 Sep 8;19(1):144. doi: 10.1186/s12985-022-01873-4.
9
Dysregulation of immunity in COVID-19 and SLE.COVID-19 与系统性红斑狼疮中的免疫失调。
Inflammopharmacology. 2022 Oct;30(5):1517-1531. doi: 10.1007/s10787-022-01047-2. Epub 2022 Aug 26.
10
Contributing factors to pediatric COVID-19 and MIS-C during the initial waves: A systematic review of 92 case reports.第一波疫情期间儿童新冠病毒感染及儿童多系统炎症综合征的促成因素：对92例病例报告的系统评价
Ann Med Surg (Lond). 2022 Sep;81:104227. doi: 10.1016/j.amsu.2022.104227. Epub 2022 Jul 31.
本文引用的文献
1
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.多中心关于儿童 2019 冠状病毒病/严重急性呼吸综合征冠状病毒 2 抗病毒药物使用的初始指导意见
J Pediatric Infect Dis Soc. 2020 Dec 31;9(6):701-715. doi: 10.1093/jpids/piaa045.
2
COVID-19 and Kawasaki Disease: Novel Virus and Novel Case.新型冠状病毒肺炎与川崎病：新型病毒与新型病例。
Hosp Pediatr. 2020 Jun;10(6):537-540. doi: 10.1542/hpeds.2020-0123. Epub 2020 Apr 7.
3
Kawasaki Disease.川崎病
Pediatr Rev. 2018 Feb;39(2):78-90. doi: 10.1542/pir.2016-0182.
4
Recognition of a Kawasaki disease shock syndrome.川崎病休克综合征的识别。
Pediatrics. 2009 May;123(5):e783-9. doi: 10.1542/peds.2008-1871.
Zotero 插件